Numerous studies have confirmed the PI3K/AKT pathway mediates multiple biological functions in ccRCC progression and metastasis40, 41, together suggesting a critical role for PI3K/AKT signaling and providing potential treatment opportunities. This evidence concerns the gene AKT1 and nonpapillary renal cell carcinoma.